Related content

Histological changes in bone marrow after treatment of infliximab for rheumatoid arthritis

By Kanbe Katsuaki   Inoue Kazuhiko   Inoue Yasuo   Suzuki Yutaka  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 497-501

Springer Publishing Company

Access to resources Recommend Favorite

Return of infliximab efficacy after total knee arthroplasty in a patient with rheumatoid arthritis

By Toki Hiroe   Momohara Shigeki   Ikari Katsunori   Kawamura Koichiro   Tsukahara So   Mochizuki Takeshi   Sato Eri   Yamanaka Hisashi  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 549-550

Springer Publishing Company

Access to resources Recommend Favorite

Polymyositis associated with infliximab treatment for rheumatoid arthritis

By Urata Yukitomo   Wakai Yuji   Kowatari Kenji   Nitobe Taisuke   Mizushima Yutaka  

Modern Rheumatology, Vol. 16, Iss. 6, 2006-12 ,pp. : 410-411

Springer Publishing Company

Access to resources Recommend Favorite

The number needed to treat for adalimumab, etanercept, and infliximab based on ACR50 response in three randomized controlled trials on established rheumatoid arthritis: a systematic literature review

By Kristensen L. E.   Christensen R.   Bliddal H.   Geborek P.   Danneskiold-Samsøe B.   Saxne T.  

Scandinavian Journal of Rheumatology, Vol. 36, Iss. 6, 2007-01 ,pp. : 411-417

Informa Healthcare

Access to resources Recommend Favorite

Comparison of in-office magnetic resonance imaging versus conventional radiography in detecting changes in erosions after one year of infliximab therapy in patients with rheumatoid arthritis

By Gaylis Norman B.   Needell Steven D.   Rudensky Daniel  

Modern Rheumatology, Vol. 17, Iss. 4, 2007-08 ,pp. : 273-278

Springer Publishing Company

Access to resources Recommend Favorite